Kenvue Inc. $KVUE Shares Sold by Voya Investment Management LLC

Voya Investment Management LLC trimmed its stake in shares of Kenvue Inc. (NYSE:KVUE) by 50.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,779,594 shares of the company’s stock after selling 4,911,623 shares during the quarter. Voya Investment Management LLC’s holdings in Kenvue were worth $77,573,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Truvestments Capital LLC acquired a new stake in Kenvue in the first quarter valued at approximately $37,000. Trust Co. of Vermont raised its holdings in shares of Kenvue by 266.8% in the 2nd quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock valued at $33,000 after purchasing an additional 1,150 shares in the last quarter. Ransom Advisory Ltd purchased a new stake in shares of Kenvue during the 1st quarter worth $56,000. First Pacific Financial acquired a new position in shares of Kenvue during the second quarter worth $54,000. Finally, UMB Bank n.a. increased its holdings in Kenvue by 22.3% in the second quarter. UMB Bank n.a. now owns 2,853 shares of the company’s stock valued at $60,000 after buying an additional 521 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

KVUE has been the subject of several analyst reports. The Goldman Sachs Group lowered their price objective on Kenvue from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Thursday, October 2nd. Rothschild Redb raised Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, September 26th. Deutsche Bank Aktiengesellschaft set a $18.00 price objective on shares of Kenvue in a report on Friday, October 24th. JPMorgan Chase & Co. lowered their target price on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating for the company in a report on Friday, October 10th. Finally, Jefferies Financial Group dropped their target price on shares of Kenvue from $25.00 to $23.00 and set a “buy” rating on the stock in a research report on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and twelve have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $20.23.

Insider Buying and Selling at Kenvue

In other Kenvue news, Director Jeffrey C. Smith acquired 3,200,000 shares of the company’s stock in a transaction dated Friday, December 12th. The stock was acquired at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the purchase, the director directly owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. 1.68% of the stock is currently owned by company insiders.

Kenvue Trading Down 0.5%

Shares of Kenvue stock opened at $17.02 on Friday. The company has a 50-day moving average of $16.29 and a two-hundred day moving average of $18.90. The stock has a market cap of $32.61 billion, a PE ratio of 22.69 and a beta of 0.60. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $25.17.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.01. The firm had revenue of $3.76 billion during the quarter, compared to analysts’ expectations of $3.83 billion. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.Kenvue’s revenue was down 3.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.28 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th were given a $0.2075 dividend. The ex-dividend date was Wednesday, November 12th. This represents a $0.83 annualized dividend and a dividend yield of 4.9%. Kenvue’s dividend payout ratio is currently 110.67%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.